Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants Orphan-drug Designation for LMTX in Frontotemporal Dementia

americanpharmaceuticalreviewDecember 11, 2018

Tag: FDA , ODD , LMTX , FTD

PharmaSources Customer Service